It’s all quite satisfactory, merci: Sanofi chairman Serge Weinberg shrugs off growing calls for an M&A deal
Sanofi has tried at least twice to land big acquisitions needed to do something to address the underlying problems that plague the French pharma giant. They got beat out twice, once purely on Pfizer CEO’s Ian Read’s willingness to outbid all comers for Medivation and the second time after Actelion took offense at some perceived bad behavior on Sanofi’s part. And they’ve been out in the market kicking tires and doing some road tests.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.